Comparison of 2 Algorithms for Adding Insulin Glargine (GLA) to Metformin (MET) in Patients (Pts) with T2DM

被引：0

|

作者：

Dailey, George

Traylor, Louise

Gill, Jasvinder

机构：

来源：

DIABETES | 2015年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1037-P

引用

收藏

页码：A266 / A266

页数：1

相关论文

共 50 条

[1] COST-UTILITY EVALUATION OF INSULIN GLARGINE 300 (GLA-300) VERSUS INSULIN GLARGINE 100 (GLA-100) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Delgado, M.
Rubio, M.
Gasche, D.
Fournier, M.
Monereo, S.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A675 - A675
[2] Insulin plus metformin for T2DM—are there benefits?
Clifford J. Bailey
[J]. Nature Reviews Endocrinology, 2012, 8 : 449 - 450
[3] Once daily insulin-glargine (LANTUS®, GLAR) initiated in groups, with metformin (MET) is a practical and effective regimen in T2DM
Gallen, IW
Carter, C
[J]. DIABETES, 2005, 54 : A561 - A561
[4] Comparison of the Effects of Insulin Detemir (IDet) and Insulin Glargine (IGlar) in Patients With Type 2 Diabetes (T2DM) in Turkey
Damci, Taner
Emral, Rifat
Svendsen, Anne Louise
Balkir, Tanzer
Vora, Jiten
[J]. DIABETES, 2013, 62 : A653 - A653
[5] β-Cell-Relieving Effects of Basal Insulin Plus Metformin (MET) Treatment in Type 2 Diabetes (T2D) Patients (Pts) Using Insulin Glargine (GLA) or NPH Insulin (NPH)
Hohberg, Cloth
Larbig, Martin
Pfuetzner, Andreas
Roth, Werner
Forst, Thomas
[J]. DIABETES, 2009, 58 : A119 - A119
[6] Change in lipid variables with insulin glargine versus pioglitazone in T2DM patients inadequately controlled on a sulfonylurea or metformin
McGill, J. B.
Traylor, L.
Dwarakanathan, A.
[J]. DIABETOLOGIA, 2007, 50 : S506 - S506
[7] Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM
Bretzel, Reinhard
Traylor, Louise
Landgraf, Wolfgang
[J]. DIABETES, 2014, 63 : A237 - A238
[8] Evaluation of Immunogenicity of LY2963016 Insulin Glargine Compared with Lantus® Insulin Glargine in Patients with T1DM or T2DM
Deeg, Mark
Ilag, Liza
Huster, William J.
Pollom, Robyn K.
Zielonka, Jason
Prince, Melvin J.
Konrad, Robert J.
[J]. DIABETES, 2014, 63 : A19 - A19
[9] A Comparison of CV-FBG in T2DM with Use of Glargine/NPH as a Basal Insulin
Mu Pan-Wei
Zeng Long-Yi
Zhang Guo-Chao
Chen Yan-Ming
Fu Jing-Yi
Wang Man-Man
[J]. DIABETES, 2010, 59 : A174 - A174
[10] Metformin safety in T2DM patients with psoriasis
[J]. Reactions Weekly, 2019, 1743 (1) : 10 - 10

← 1 2 3 4 5 →